Gi Anatomy Part 4 Liver Gallbladder Pancreas D.Hammoudi.Md
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Engineered Liver-On-A-Chip Platform to Mimic Liver Functions and Its Biomedical Applications: a Review
micromachines Review Engineered Liver-On-A-Chip Platform to Mimic Liver Functions and Its Biomedical Applications: A Review 1, 1, 2, 1, 1 Jiu Deng y, Wenbo Wei y, Zongzheng Chen y , Bingcheng Lin *, Weijie Zhao , Yong Luo 1 and Xiuli Zhang 3,* 1 State Key Laboratory of Fine Chemicals, Department of Chemical Engineering, Dalian University of Technology, Dalian 116024, China; [email protected] (J.D.); [email protected] (W.W.); [email protected] (W.Z.); [email protected] (Y.L.) 2 Integrated Chinese and Western Medicine Postdoctoral research station, Jinan University, Guangzhou 510632, China; [email protected] 3 College of Pharmaceutical Science, Soochow University, Suzhou 215123, China * Correspondence: [email protected] (B.L.); [email protected] (X.Z.); Tel.: +86-0411-8437-9065 (B.L.); +86-155-0425-7723 (X.Z.) These authors have equally contribution to this work. y Received: 17 September 2019; Accepted: 3 October 2019; Published: 7 October 2019 Abstract: Hepatology and drug development for liver diseases require in vitro liver models. Typical models include 2D planar primary hepatocytes, hepatocyte spheroids, hepatocyte organoids, and liver-on-a-chip. Liver-on-a-chip has emerged as the mainstream model for drug development because it recapitulates the liver microenvironment and has good assay robustness such as reproducibility. Liver-on-a-chip with human primary cells can potentially correlate clinical testing. Liver-on-a-chip can not only predict drug hepatotoxicity and drug metabolism, but also connect other artificial organs on the chip for a human-on-a-chip, which can reflect the overall effect of a drug. -
Heart Vein Artery
1 PRE-LAB EXERCISES Open the Atlas app. From the Views menu, go to System Views and scroll down to Circulatory System Views. You are responsible for the identification of all bold terms. A. Circulatory System Overview In the Circulatory System Views section, select View 1. Circulatory System. The skeletal system is included in this view. Note that blood vessels travel throughout the entire body. Heart Artery Vein 2 Brachiocephalic trunk Pulmonary circulation Pericardium 1. Where would you find the blood vessels with the largest diameter? 2. Select a few vessels in the leg and read their names. The large blue-colored vessels are _______________________________ and the large red-colored vessels are_______________________________. 3. In the system tray on the left side of the screen, deselect the skeletal system icon to remove the skeletal system structures from the view. The largest arteries and veins are all connected to the _______________________________. 4. Select the heart to highlight the pericardium. Use the Hide button in the content box to hide the pericardium from the view and observe the heart muscle and the vasculature of the heart. 3 a. What is the largest artery that supplies the heart? b. What are the two large, blue-colored veins that enter the right side of the heart? c. What is the large, red-colored artery that exits from the top of the heart? 5. Select any of the purple-colored branching vessels inside the rib cage and use the arrow in the content box to find and choose Pulmonary circulation from the hierarchy list. This will highlight the circulatory route that takes deoxygenated blood to the lungs and returns oxygenated blood back to the heart. -
Vessels and Circulation
CARDIOVASCULAR SYSTEM OUTLINE 23.1 Anatomy of Blood Vessels 684 23.1a Blood Vessel Tunics 684 23.1b Arteries 685 23.1c Capillaries 688 23 23.1d Veins 689 23.2 Blood Pressure 691 23.3 Systemic Circulation 692 Vessels and 23.3a General Arterial Flow Out of the Heart 693 23.3b General Venous Return to the Heart 693 23.3c Blood Flow Through the Head and Neck 693 23.3d Blood Flow Through the Thoracic and Abdominal Walls 697 23.3e Blood Flow Through the Thoracic Organs 700 Circulation 23.3f Blood Flow Through the Gastrointestinal Tract 701 23.3g Blood Flow Through the Posterior Abdominal Organs, Pelvis, and Perineum 705 23.3h Blood Flow Through the Upper Limb 705 23.3i Blood Flow Through the Lower Limb 709 23.4 Pulmonary Circulation 712 23.5 Review of Heart, Systemic, and Pulmonary Circulation 714 23.6 Aging and the Cardiovascular System 715 23.7 Blood Vessel Development 716 23.7a Artery Development 716 23.7b Vein Development 717 23.7c Comparison of Fetal and Postnatal Circulation 718 MODULE 9: CARDIOVASCULAR SYSTEM mck78097_ch23_683-723.indd 683 2/14/11 4:31 PM 684 Chapter Twenty-Three Vessels and Circulation lood vessels are analogous to highways—they are an efficient larger as they merge and come closer to the heart. The site where B mode of transport for oxygen, carbon dioxide, nutrients, hor- two or more arteries (or two or more veins) converge to supply the mones, and waste products to and from body tissues. The heart is same body region is called an anastomosis (ă-nas ′tō -mō′ sis; pl., the mechanical pump that propels the blood through the vessels. -
Nomina Histologica Veterinaria, First Edition
NOMINA HISTOLOGICA VETERINARIA Submitted by the International Committee on Veterinary Histological Nomenclature (ICVHN) to the World Association of Veterinary Anatomists Published on the website of the World Association of Veterinary Anatomists www.wava-amav.org 2017 CONTENTS Introduction i Principles of term construction in N.H.V. iii Cytologia – Cytology 1 Textus epithelialis – Epithelial tissue 10 Textus connectivus – Connective tissue 13 Sanguis et Lympha – Blood and Lymph 17 Textus muscularis – Muscle tissue 19 Textus nervosus – Nerve tissue 20 Splanchnologia – Viscera 23 Systema digestorium – Digestive system 24 Systema respiratorium – Respiratory system 32 Systema urinarium – Urinary system 35 Organa genitalia masculina – Male genital system 38 Organa genitalia feminina – Female genital system 42 Systema endocrinum – Endocrine system 45 Systema cardiovasculare et lymphaticum [Angiologia] – Cardiovascular and lymphatic system 47 Systema nervosum – Nervous system 52 Receptores sensorii et Organa sensuum – Sensory receptors and Sense organs 58 Integumentum – Integument 64 INTRODUCTION The preparations leading to the publication of the present first edition of the Nomina Histologica Veterinaria has a long history spanning more than 50 years. Under the auspices of the World Association of Veterinary Anatomists (W.A.V.A.), the International Committee on Veterinary Anatomical Nomenclature (I.C.V.A.N.) appointed in Giessen, 1965, a Subcommittee on Histology and Embryology which started a working relation with the Subcommittee on Histology of the former International Anatomical Nomenclature Committee. In Mexico City, 1971, this Subcommittee presented a document entitled Nomina Histologica Veterinaria: A Working Draft as a basis for the continued work of the newly-appointed Subcommittee on Histological Nomenclature. This resulted in the editing of the Nomina Histologica Veterinaria: A Working Draft II (Toulouse, 1974), followed by preparations for publication of a Nomina Histologica Veterinaria. -
Analysis of the Sinusoidal Endothelial Cell Organization During The
CELL STRUCTURE AND FUNCTION 23: 341-348 (1998) © 1998 by Japan Society for Cell Biology Analysis of the Sinusoidal Endothelial Cell Organization during the Develop- mental Stage of the Fetal Rat Liver Using a Sinusoidal Endothelial Cell Specific Antibody, SE-1 Mamoru Morita1, Wang Qun2, Hitoshi Watanabe1, Yuko Doi1, Michio Mori3, and Katsuhiko Enomoto1'* department of Pathology, Akita University School of Medicine, Hondo, Akita 010-8543, Japan, depart- ment of Pathology, School of Basic Medicine, NormanBethune University of Medical Science, Jilin, P.R. of China, and *Department of Pathology, Sapporo Medical University School of Medicine, S-l, W-17, Chuo-ku, Sapporo 060, Japan Keywords: sinusoidal endothelial cells/SE-1 antibody/fetal rat liver ABSTRACT.The sinusoid organization during the development of fetal rat livers was studied using a SE-1 antibody, which we have previously established as a specific monoclonal antibody against rat sinusoidal endo- thelial cell (SEC). Expression and localization of the SE-1 antigen in the liver tissues of 13- to 21-day-old fe- tuses were immunofluorescently and immunoelectron microscopically examined. The first positive fluorescence was observed in the immature liver of 15-day-old fetuses. The initial positive staining was randomly distrib- uted in the liver parenchyma and showed no direct relation to the large vessels which may be derived from the fetal vitelline veins. The positive linear staining increased in number and connected with each other during the course of development. The SE-1 staining pattern and the sinusoidal arrangement became similar to those of the adult liver after 20th day of gestation. Immunoelectron microscopically, the immature SEC showed a weak positive reaction for the SE-1 antigen at their membraneand was observed together with immature hepato- cytes and hematopoietic cells in the 15-day-old fetal liver. -
Title of My Thesis
Development of an in vitro 3D Printed Liver Sinusoid Model Soumya Sethi A Dissertation Submitted to Indian Institute of Technology Hyderabad In Partial Fulfillment of the Requirements for The Degree of Master of Technology Department of Biomedical Engineering June, 2018 Declaration I declare that this written submission represents my ideas in my own words, and where others’ ideas or words have been included, I have adequately cited and referenced the original sources. I also declare that I have adhered to all principles of academic honesty and integrity and have not misrepresented or fabricated or falsified any idea/data/fact/source in my submission. I understand that any violation of the above will be a cause for disciplinary action by the Institute and can also evoke penal action from the sources that have thus not been properly cited, or from whom proper permission has not been taken when needed. (Signature) Soumya Sethi BM16MTECH11007 (Roll No) ii Approval Sheet iii Acknowledgements I would like to thank my thesis supervisor Dr Falguni Pati for his continuous guidance. I would also like to thank my lab members especially Shibu Chameettachal, Shyama Sasikumar, Sriya for supporting me and helping me out whenever required. They have been a continuous source of inspiration for me, without their passionate participation and inputs, the project could not have been successfully conducted. iv Abstract Liver is one of the most remarkable organs of the human body as it performs various vital functions namely metabolism of fats and carbohydrates, drugs, detoxification, production of bile and has a capacity to regenerate. The intricate functional units of the liver called the sinusoids are of immense interest as they are early targets of many drugs and toxicants as well as have been reported to play a significant role in initiating liver regeneration and contribute to the pathophysiology of many liver diseases. -
Review Article
JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY 2008, 59, Suppl 2, 231238 www.jpp.krakow.pl Review article H. CICHO¯-LACH, K. CELIÑSKI, M. S£OMKA, B. KASZTELAN-SZCZERBIÑSKA PATHOPHYSIOLOGY OF PORTAL HYPERTENSION Department of Gastroenterology Medical University of Lublin, Poland In last years significant progress in recognizing mechanisms of portal hypertension pathophysiology was done. However, some unclear topics in this disease still exist. Portal hypertension is primarily caused by the increase in resistance to portal outflow and secondly by an increase in splanchnic blood flow. Portal hypertension is associated with changes in the intrahepatic, systemic, and portosystemic collateral circulation. Alterations in vasoreactivity (vasodilation and vasoconstriction) play a central role in the pathophysiology of portal hypertension by contributing to increased intrahepatic resistance, hyperdynamic circulation, and expansion of the collateral circulation. Among vasoactive substances which are activated in portal hypertension nitric oxide (NO) is considered as the most important vasodilator. Endothelin-1 and cyclooxygenase-derived prostaglandins are the main vasoconstrictor factors. The imbalance between the hyperresponsiveness and overproduction of vasoconstrictors and the hyporesponsiveness and impaired production of vasodilators are the mechanisms responsible of the increased vascular tone in the sinusoidal area of the liver. New concepts in the pathophysiology of portal hypertension find the significant role of hepatic stellate cells activated by endothelial factors which cause vascular remodeling as an adaptive response of the portal vessels wall. The most frequent causes of portal hypertension include portal vein thrombosis, storage diseases of the liver, hepatic cirrhosis (independent of etiology), hepatic veins thrombosis and schistosomiasis. Understanding the pathophysiology of portal hypertension could be of great utility in preventing and curing the complications of portal hypertension, such as esophageal varices, hepatic encephalopathy, ascites. -
Elimination Pathways of Nanoparticles † ‡ † ‡ ◆ † ‡ § ◆ † ‡ † ‡ Wilson Poon, , Yi-Nan Zhang, , , Ben Ouyang, , , , Benjamin R
Article Cite This: ACS Nano 2019, 13, 5785−5798 www.acsnano.org Elimination Pathways of Nanoparticles † ‡ † ‡ ◆ † ‡ § ◆ † ‡ † ‡ Wilson Poon, , Yi-Nan Zhang, , , Ben Ouyang, , , , Benjamin R. Kingston, , Jamie L. Y. Wu, , ∥ ⊥ † ‡ # ∇ ○ Stefan Wilhelm, , and Warren C. W. Chan*, , , , , † Institute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto, Ontario M5S 3G9, Canada ‡ Terrence Donnelly Centre for Cellular and Biomolecular Research, University of Toronto, Toronto, Ontario M5S 3E1, Canada § MD/PhD Program, Faculty of Medicine, University of Toronto, Toronto, Ontario M5S 1A8, Canada ∥ Stephenson School of Biomedical Engineering, University of Oklahoma, Norman, Oklahoma 73019, United States ⊥ Stephenson Cancer Center, Oklahoma City, Oklahoma 73104, United States # Department of Chemical Engineering and Applied Chemistry, University of Toronto, Toronto, Ontario M5S 3E5, Canada ∇ Department of Materials Science and Engineering, University of Toronto, Toronto, Ontario M5S 1A1, Canada ○ Department of Chemistry, University of Toronto, Toronto, Ontario M5S 3H6, Canada *S Supporting Information ABSTRACT: Understanding how nanoparticles are eliminated from the body is required for their successful clinical translation. Many promising nanoparticle formulations for in vivo medical applications are large (>5.5 nm) and nonbiodegradable, so they cannot be eliminated renally. A proposed pathway for these nanoparticles is hepatobiliary from https://pubs.acs.org/doi/10.1021/acsnano.9b01383. elimination, but their transport has -
The Influence of Chronic Liver Diseases on Hepatic Vasculature
micromachines Review The Influence of Chronic Liver Diseases on Hepatic Vasculature: A Liver-on-a-chip Review Alican Özkan 1,* , Danielle Stolley 2, Erik N. K. Cressman 3 , Matthew McMillin 4,5 , Sharon DeMorrow 4,5,6 , Thomas E. Yankeelov 2,7,8,9,10 and Marissa Nichole Rylander 1,2,7 1 Department of Mechanical Engineering, The University of Texas, Austin, TX 78712, USA; [email protected] 2 Department of Biomedical Engineering, The University of Texas, Austin, TX 78712, USA; [email protected] (D.S.); [email protected] (T.E.Y.) 3 Department of Interventional Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; [email protected] 4 Department of Internal Medicine, Dell Medical School, The University of Texas at Austin, Austin, TX 78713, USA; [email protected] (M.M.); [email protected] (S.D.) 5 Central Texas Veterans Health Care System, Temple, TX 76504, USA 6 Division of Pharmacology and Toxicology, College of Pharmacy, The University of Texas at Austin, Austin, TX 78712, USA 7 Oden Institute for Computational Engineering and Sciences, The University of Texas, Austin, TX 78712, USA 8 Departments of Diagnostic Medicine, The University of Texas, Austin, TX 78712, USA 9 Department of Oncology, The University of Texas, Austin, TX 78712, USA 10 Livestrong Cancer Institutes, Dell Medical School, The University of Texas, Austin, TX 78712, USA * Correspondence: [email protected]; Tel.: +1-512-806-9062 Received: 16 April 2020; Accepted: 4 May 2020; Published: 9 May 2020 Abstract: In chronic liver diseases and hepatocellular carcinoma, the cells and extracellular matrix of the liver undergo significant alteration in response to chronic injury. -
Descriptive Anatomy of Hepatic and Portal Veins with Special Reference
Brazilian Journal of Poultry Science Revista Brasileira de Ciência Avícola Descriptive Anatomy of Hepatic and Portal Veins ISSN 1516-635X 2019 / v.21 / n.2 / 001-012 with Special Reference to Biliary Duct System in Broiler Chickens (Gallus gallus domesticus): http://dx.doi.org/10.1590/1806-9061-2019-0980 A Recent Illustration Original Article Author(s) ABSTRACT Maher MAI https://orcid.org/0000-0002-7040-7813 Chickens have a great participation in meat and egg production. The anatomical scientific data of poultry is important to support the recent researches either for illustrations in academic studies or clinically in diagnosis and treatment of some poultry nutritional diseases. The current investigation was performed on twenty broiler chickens of both sexes. The chickens were anaesthetized, slaughtered then the venous system was flushed with a normal saline to anatomically investigate the distribution of hepatic portal veins both intra and extrahepatic, as well as the hepatic venous and biliary duct systems. The fowl had two hepatic portal veins draining the gastrointestinal tract with its associated organs as spleen and pancreas. The left hepatic portal vein was small, restricted to a limited portion of left hepatic lobe and had been constituted by five main venous tributaries draining the proventriculus, gizzard and pylorus, while the right hepatic portal vein was the largest, receiving the proventriculosplenic, gastropancreaticoduodenal and common mesenteric veins then piercing the right hepatic lobe to be distributed in both hepatic segments through right and left divisions. The fowl has two hepatic portal veins differed in size and distribution. A characteristic imaginary trapezoid shape was formed by some tributaries draining the caudoventral part of the gizzard. -
Original Article Rat Liver Sinusoidal Dilatation Induced by Perfusion In
Int J Clin Exp Med 2016;9(6):11284-11291 www.ijcem.com /ISSN:1940-5901/IJCEM0021986 Original Article Rat liver sinusoidal dilatation induced by perfusion in vitro through portal vein alone, hepatic artery alone, and portal vein together with hepatic artery Hefang Shen1, Jing Dong1, Lingling Xia2, Jianjian Xu3, Lili Xu1 1School of Basic Medical Science, Anhui Medical University, Hefei, Anhui 230032, People’s Republic of China; 2Department of Infectious Diseases, The First Affiliated Hospital of Anhui Medical University, Anhui, People’s Republic of China; 3School of Medical Engineering, Hefei University of Technology, Hefei, Anhui 230009, People’s Republic of China Received December 15, 2015; Accepted February 4, 2016; Epub June 15, 2016; Published June 30, 2016 Abstract: The techniques for liver perfusion have been recommended in order to protect liver grafts prior to trans- plantation. We compared portal vein alone, hepatic artery alone, and dual perfusion through portal vein together with hepatic artery perfusion techniques in rat livers analyzed in histology. Rat livers were treated for 30 min in situ warm ischemia and excised and directly placed to mimic conventional cold storage for 4 hours followed by different routes of cold perfusion. In three experimental groups, five livers were given portal vein perfusion in group one. In group two, five livers were subjected to hepatic artery perfusion and in group three five livers received both portal vein and hepatic artery perfusion. Histological samples were taken before the beginning of the perfusion, 30 min- utes, and 60 minutes after starting of the perfusion. Rat livers, received portal vein perfusion in group one, revealed remarkable sinusoidal dilatation increasingly with augmented perfusion time. -
Cirrhosis and Its Complications Catch This Liver Scarring Problem Early, Because Its Effects Can Be Life-Threatening
Cirrhosis and Its Complications Catch this liver scarring problem early, because its effects can be life-threatening By Scott R. Snyder, BS, NREMT-P, Sean M. Kivlehan, MD, MPH, NREMT-P, & Kevin T. Collopy, BA, FP-C, CCEMT-P, NREMT-P, WEMT This month’s CE article looks at cirrhosis and its complications. In an attempt to best understand the signs and symptoms and progression of this disease, we will review the anatomy, physiology and pathophysiology of the liver and cirrhosis and the clinical manifestations of the disease and its complications. ANATOMY OF THE LIVER The liver is the largest visceral organ in the body, and the majority of its mass is located in the upper right abdominal quadrant and extends into the upper left quadrant, lying directly below the diaphragm. It weighs about 3.3 lbs. (1.5 kg) in the average adult male. The liver is encased in a tough, fi brous capsule (Glisson’s capsule) and covered by a layer of visceral peritoneum. It is held in place in the abdomen by several ligaments, including the falciform, round and coronary ligaments. The gallbladder is a small, hollow, pear-shaped muscular sac that lies on the posterior surface of the liver. While not a true part of the liver, it works closely with the liver to store and secrete bile produced in the liver to aid digestion. Blood Supply The liver is the largest blood reservoir in the body, receiving about 25% of the cardiac output. It is unique in that it has a double blood supply, receiving blood from both the hepatic portal vein and hepatic arteries.